Surveillance for Neisseria meningitidis Disease Activity and Transmission Using Information Technology

• S. Sohail Ahmed ,

  * E-mail: sohail.q.ahmed@gsk.com

  Current address: Global Clinical Sciences, GSK, Siena, Italy

  Affiliation Global Clinical Sciences, Novartis Vaccines Srl, Siena, Italy

  ⨯
• Ernesto Oviedo-Orta,

  Current address: Global Clinical Sciences, GSK, Siena, Italy

  Affiliation Global Clinical Sciences, Novartis Vaccines Srl, Siena, Italy

  ⨯
• Sumiko R. Mekaru,

  Affiliation Children’s Hospital Informatics Program at the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Computational Epidemiology Group, Boston, Massachusetts, United States of America

  ⨯
• Clark C. Freifeld,

  Affiliation Children’s Hospital Informatics Program at the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Computational Epidemiology Group, Boston, Massachusetts, United States of America

  ⨯
• Gervais Tougas,

  Affiliation Drug Safety and Epidemiology, Novartis Pharma AG, Basel, Switzerland

  ⨯
• John S. Brownstein

  Affiliations Children’s Hospital Informatics Program at the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Computational Epidemiology Group, Boston, Massachusetts, United States of America, Department of Pediatrics, Harvard Medical School, Boston Children’s Hospital, Boston, Massachusetts, United States of America

  ⨯